文献速递乳房整形与再造创面修复

感染乳房假体的挽救治疗:80例回顾性系列结果

Salvaging the infected breast implant: results of a retrospective series of 80 consecutive cases.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-05-25

该回顾性系列分析2005年至2018年80例有临床感染征象且细菌学阳性的乳房假体感染患者,77例首选内科治疗、3例首选手术。总体假体挽救成功率88.8%(71例),其中73.8%仅需内科治疗、15%内科治疗后手术;主要致病菌为葡萄球菌(81.2%),凝固酶阴性葡萄球菌感染成功率98%(p<0.003)。

要点

  • 有临床感染征象且细菌学阳性的乳房假体感染,总体挽救成功率达88.8%。
  • 多数患者仅需抗生素等内科治疗即可保住假体。
  • 凝固酶阴性葡萄球菌感染成功率98%(p<0.003),早期干预是成功关键。

核心结论

  • 有明确感染的乳房假体挽救在高达90%的女性中可实现,多数仅需抗生素管理。
  • 早期干预是挽救成功的中心环节。

研究设计与样本

  • 回顾性分析2005年1月至2018年1月间所有发生乳房假体感染的患者。
  • 纳入标准为同时具备临床感染征象和阳性细菌学样本。
  • 患者分为首选内科治疗组(含需二期手术挽救者)与首选手术组。
  • 挽救成功定义为初次重建后3个月时假体仍在位。

主要发现

  • 共纳入80例患者:内科组77例,手术组3例。
  • 总体假体挽救成功率为88.8%(71例)。
  • 73.8%(59例)仅接受内科治疗,15%(12例)接受内科治疗后手术处理。
  • 主要致病菌为葡萄球菌,占81.2%。
  • 凝固酶阴性葡萄球菌所致感染的成功率为98%(p<0.003)。

临床怎么用

  • 对具备临床感染征象且细菌学阳性的乳房假体感染,可优先考虑尝试挽救而非直接取出假体。
  • 多数患者可通过内科治疗(抗生素等)保住假体,部分需联合手术冲洗等处理。
  • 应早期干预以提高挽救成功率。

局限性

  • 为回顾性病例系列,非对照研究。
  • 手术组仅3例,组间比较受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast implants are widely used in reconstruction after breast cancer. Infection after implant reconstruction is a major complication, with rates ranging from 5 to 30%. This rate is less for pure cosmetic augmentation. Historically, infection of an implant mandated implant removal for sepsis control. An alternative is to attempt to salvage the infected implant. This path can be a long one, requiring surgery for washouts and prolonged antibiotic therapy. This article documents our experience of infected implant salvage over the last 13 years. METHODS: We conducted a retrospective analysis of all patients who developed a breast implant infection between January 2005 and January 2018. All patients had both clinical signs of infection and a positive bacteriological sample. Patients were divided into two groups: upfront medical therapy (including those requiring secondary surgical salvage) and primary surgery. The salvage procedure was defined as successful when the implant was still in place three months after the initial reconstruction. RESULTS: Eighty patients were included: 77 in the medical group and 3 in the surgical group. Overall, implant salvage was achieved in 88.8% of women (n=71). Of these, 73.8% (n=59) underwent medical treatment alone and 15% (n=12) underwent medical treatment followed by surgical management. The main causative organism was staphylococcus in 81.2%. When the infection was caused by a coagulase-negative staphylococcus, the rate of success was 98% (p<0.003). CONCLUSIONS: This case series reports that salvage of an infected breast implant was achievable in up to 90% of women presenting with a documented infection, the majority requiring antibiotic management only. Early intervention is central to success.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Sarfati I, Millochau J, Meredith I, et al. Salvaging the infected breast implant: results of a retrospective series of 80 consecutive cases. J Plast Reconstr Aesthet Surg. 2020. PMID: 32601014. doi:10.1016/j.bjps.2020.05.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。